<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://wiki.mininuniver.ru/index.php?action=history&amp;feed=atom&amp;title=~Delete_11711</id>
	<title>~Delete 11711 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.mininuniver.ru/index.php?action=history&amp;feed=atom&amp;title=~Delete_11711"/>
	<link rel="alternate" type="text/html" href="https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;action=history"/>
	<updated>2026-05-07T03:45:39Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=408697&amp;oldid=prev</id>
		<title>Moderator: Moderator переименовал страницу Disconcerting Approaches Of Rule With The Help Of MDV3100,arq197, Cyclopamine, MDV3100 в ~Delete 11711: Spam</title>
		<link rel="alternate" type="text/html" href="https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=408697&amp;oldid=prev"/>
		<updated>2025-12-24T00:40:46Z</updated>

		<summary type="html">&lt;p&gt;Moderator переименовал страницу &lt;a href=&quot;/index.php/Disconcerting_Approaches_Of_Rule_With_The_Help_Of_MDV3100,arq197,_Cyclopamine,_MDV3100&quot; class=&quot;mw-redirect&quot; title=&quot;Disconcerting Approaches Of Rule With The Help Of MDV3100,arq197, Cyclopamine, MDV3100&quot;&gt;Disconcerting Approaches Of Rule With The Help Of MDV3100,arq197, Cyclopamine, MDV3100&lt;/a&gt; в &lt;a href=&quot;/index.php/~Delete_11711&quot; title=&quot;~Delete 11711&quot;&gt;~Delete 11711&lt;/a&gt;: Spam&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ru&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Предыдущая&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Версия 00:40, 24 декабря 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;ru&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(нет различий)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Moderator</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=408696&amp;oldid=prev</id>
		<title>Moderator: Spam cleanup</title>
		<link rel="alternate" type="text/html" href="https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=408696&amp;oldid=prev"/>
		<updated>2025-12-24T00:40:44Z</updated>

		<summary type="html">&lt;p&gt;Spam cleanup&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ru&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Предыдущая&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Версия 00:40, 24 декабря 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Строка 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Строка 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Treatment method of prostate most cancers cells with SGI-1776 resulted in a dose-dependent reduction in phosphorylation of properly-known Pim kinase substrates that are incorporated in cell cycle development and apoptosis (p21(Cip1/WAF1) and Poor).&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Content removed&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;For that reason, SGI-1776 compromised overall mobile viability by inducing G(1) cell cycle arrest and triggering apoptosis. Overexpression of recombinant Pim-one markedly improved sensitivity of SGI-1776-mediated prostate most cancers mobile apoptosis and p21(Cip1/WAF1) phosphorylation inhibition, reinforcing the specificity of SGI-1776. An added cytotoxic effect was observed when SGI-1776 was mixed with taxane-mainly based chemotherapy brokers. SGI-1776 was equipped to lower cellular viability in a multidrug resistance a single protein-mostly based taxane-refractory prostate most cancers mobile line. In addition, SGI-1776 procedure was ready to resensitize chemoresistant cells to taxane-dependent largely therapies by inhibiting multidrug resistance one exercise and inducing apoptosis. These results support the thought that inhibiting Pim kinases, in blend with a chemotherapeutic agent, could engage in an substantial position in prostate most cancers treatment by targeting the healthcare obstacle of chemoresistance.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;The Notch signaling pathway is a truly conserved developmental pathway, which performs a vital function in cellular-future variety, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a extensive selection of malignancies, and can behave as probably an oncogene or a tumor suppressor based mostly on mobile context. This critique highlights the current evidence for aberration of the Notch signaling pathway in a broad assortment of tumors from hematological cancers, like as leukemia and lymphoma through to pores and skin, breast, lung, pancreas, colon and brain tumors. It proposes that the Notch signaling pathway may probably stand for novel therapeutic targets and will be a welcome asset to the most cancers therapeutic arena.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;The Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway mediates cellular responses to various development indicators and is routinely deregulated in cancer. There are a couple of Raf kinases-A-Raf, B-Raf, and C-Raf even so, only B-Raf is usually mutated in several cancers. The most recurrent B-Raf mutation involves a substitution of a glutamic acid residue to a valine moiety at codon 600. Subsequently, the MAPK pathway is constitutively activated, even in the absence of any expansion alerts. Despite the simple fact that early helps make an endeavor to goal Ras have not yielded any useful drug candidates, plenty of novel compounds inhibiting the pursuits of Raf and MEK have been designed and investigated in health care trials in new a long time. The quite initial MEK inhibitor (CI-1040) lacked efficacy in health-related trials, but its little toxicity has inspired the seem for for novel compounds with enhanced objective performance to inhibit MAPK activation at modest nanomolar concentrations. In this review, we will go more than new patents or patent applications correlated to inhibitors of the Ras/Raf/MEK/ERK pathway.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Networks of sign transducers establish the transformation of environmental cues into mobile steps. Amongst the significant avid gamers in these networks are protein kinases, which can acutely and reversibly modify protein features to impact mobile capabilities. 1 distinct staff of kinases, the protein kinase Do (PKC) close friends and family, have been more and a lot more implicated in the firm of indicator propagation, considerably in the spatial distribution of indicators. [http://www.selleck.jp/products/arq-197.html ARQ 197 availability], [http://www.selleck.jp/products/MDV3100.html MDV3100 Androgen Receptor inhibitor], [http://www.selleck.jp/products/Cyclopamine.html Cyclopamine price]&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Moderator</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=133247&amp;oldid=prev</id>
		<title>Saw67pencil: Новая: Treatment method of prostate most cancers cells with SGI-1776 resulted in a dose-dependent reduction in phosphorylation of properly-known Pim kinase substrates that are incorporated in c...</title>
		<link rel="alternate" type="text/html" href="https://wiki.mininuniver.ru/index.php?title=~Delete_11711&amp;diff=133247&amp;oldid=prev"/>
		<updated>2013-05-04T10:05:39Z</updated>

		<summary type="html">&lt;p&gt;Новая: Treatment method of prostate most cancers cells with SGI-1776 resulted in a dose-dependent reduction in phosphorylation of properly-known Pim kinase substrates that are incorporated in c...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Treatment method of prostate most cancers cells with SGI-1776 resulted in a dose-dependent reduction in phosphorylation of properly-known Pim kinase substrates that are incorporated in cell cycle development and apoptosis (p21(Cip1/WAF1) and Poor).&lt;br /&gt;
For that reason, SGI-1776 compromised overall mobile viability by inducing G(1) cell cycle arrest and triggering apoptosis. Overexpression of recombinant Pim-one markedly improved sensitivity of SGI-1776-mediated prostate most cancers mobile apoptosis and p21(Cip1/WAF1) phosphorylation inhibition, reinforcing the specificity of SGI-1776. An added cytotoxic effect was observed when SGI-1776 was mixed with taxane-mainly based chemotherapy brokers. SGI-1776 was equipped to lower cellular viability in a multidrug resistance a single protein-mostly based taxane-refractory prostate most cancers mobile line. In addition, SGI-1776 procedure was ready to resensitize chemoresistant cells to taxane-dependent largely therapies by inhibiting multidrug resistance one exercise and inducing apoptosis. These results support the thought that inhibiting Pim kinases, in blend with a chemotherapeutic agent, could engage in an substantial position in prostate most cancers treatment by targeting the healthcare obstacle of chemoresistance.&lt;br /&gt;
The Notch signaling pathway is a truly conserved developmental pathway, which performs a vital function in cellular-future variety, tissue patterning and morphogenesis. There is increasing evidence that this pathway is dysregulated in a extensive selection of malignancies, and can behave as probably an oncogene or a tumor suppressor based mostly on mobile context. This critique highlights the current evidence for aberration of the Notch signaling pathway in a broad assortment of tumors from hematological cancers, like as leukemia and lymphoma through to pores and skin, breast, lung, pancreas, colon and brain tumors. It proposes that the Notch signaling pathway may probably stand for novel therapeutic targets and will be a welcome asset to the most cancers therapeutic arena.&lt;br /&gt;
The Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway mediates cellular responses to various development indicators and is routinely deregulated in cancer. There are a couple of Raf kinases-A-Raf, B-Raf, and C-Raf even so, only B-Raf is usually mutated in several cancers. The most recurrent B-Raf mutation involves a substitution of a glutamic acid residue to a valine moiety at codon 600. Subsequently, the MAPK pathway is constitutively activated, even in the absence of any expansion alerts. Despite the simple fact that early helps make an endeavor to goal Ras have not yielded any useful drug candidates, plenty of novel compounds inhibiting the pursuits of Raf and MEK have been designed and investigated in health care trials in new a long time. The quite initial MEK inhibitor (CI-1040) lacked efficacy in health-related trials, but its little toxicity has inspired the seem for for novel compounds with enhanced objective performance to inhibit MAPK activation at modest nanomolar concentrations. In this review, we will go more than new patents or patent applications correlated to inhibitors of the Ras/Raf/MEK/ERK pathway.&lt;br /&gt;
Networks of sign transducers establish the transformation of environmental cues into mobile steps. Amongst the significant avid gamers in these networks are protein kinases, which can acutely and reversibly modify protein features to impact mobile capabilities. 1 distinct staff of kinases, the protein kinase Do (PKC) close friends and family, have been more and a lot more implicated in the firm of indicator propagation, considerably in the spatial distribution of indicators. [http://www.selleck.jp/products/arq-197.html ARQ 197 availability], [http://www.selleck.jp/products/MDV3100.html MDV3100 Androgen Receptor inhibitor], [http://www.selleck.jp/products/Cyclopamine.html Cyclopamine price]&lt;/div&gt;</summary>
		<author><name>Saw67pencil</name></author>
		
	</entry>
</feed>